Variant report
Variant | esv3326979 |
---|---|
Chromosome Location | chr10:25535995-25555648 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370957317 | chr10:25542014-25542015 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2491196 | chr10:25542017-25542018 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541646133 | chr10:25542018-25542019 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs61855493 | chr10:25542037-25542038 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532909211 | chr10:25542097-25542098 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549359346 | chr10:25542098-25542099 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs373599483 | chr10:25542112-25542113 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569322090 | chr10:25542121-25542122 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529108206 | chr10:25542166-25542167 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549031184 | chr10:25542167-25542168 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559312294 | chr10:25542168-25542169 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139336466 | chr10:25542197-25542198 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557977106 | chr10:25542201-25542202 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185708919 | chr10:25542204-25542205 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12762022 | chr10:25542205-25542206 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572813660 | chr10:25542206-25542207 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113599813 | chr10:25542209-25542210 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371582841 | chr10:25542210-25542211 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539949096 | chr10:25542211-25542212 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556550826 | chr10:25542225-25542226 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576526472 | chr10:25542226-25542227 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536121049 | chr10:25542232-25542233 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147370757 | chr10:25542233-25542234 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10828767 | chr10:25542238-25542239 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs542368341 | chr10:25542243-25542244 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564742778 | chr10:25542249-25542250 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs375235717 | chr10:25542261-25542262 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577281223 | chr10:25542269-25542270 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373982435 | chr10:25542270-25542271 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185397499 | chr10:25542271-25542272 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562918983 | chr10:25542272-25542273 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs139573660 | chr10:25542291-25542292 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113904293 | chr10:25542295-25542296 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147569621 | chr10:25542298-25542299 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148689786 | chr10:25542378-25542379 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188421125 | chr10:25542480-25542481 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs571469334 | chr10:25542488-25542489 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539913144 | chr10:25542526-25542527 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542792395 | chr10:25542556-25542557 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575854196 | chr10:25542585-25542586 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550311920 | chr10:25542594-25542595 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530044985 | chr10:25542614-25542615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544831451 | chr10:25542619-25542620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138434614 | chr10:25542620-25542621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181900645 | chr10:25542638-25542639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555779720 | chr10:25542639-25542640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs572641181 | chr10:25542678-25542679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560923988 | chr10:25542715-25542716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564821264 | chr10:25542735-25542736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs187670381 | chr10:25542740-25542741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Esophageal cancer | 21851588 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Behavioral abnormalities | 21522184 | CNVD |
Dysmorphic features | 21522184 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 21439084 | CNVD |
Maculopathy | 20981449 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:25542000-25542400 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
2 | chr10:25542200-25542400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr10:25542200-25542400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr10:25542200-25542600 | Active TSS | HUES6 Cell Line | embryonic stem cell |
5 | chr10:25542400-25545200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
6 | chr10:25542800-25543800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
7 | chr10:25543800-25544200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr10:25545800-25546400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
9 | chr10:25547800-25548000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
10 | chr10:25548000-25548200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
11 | chr10:25548000-25548600 | Enhancers | HepG2 | liver |
12 | chr10:25548200-25549400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
13 | chr10:25549400-25550000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr10:25549400-25551200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
15 | chr10:25550200-25551800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
16 | chr10:25551200-25553400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
17 | chr10:25553400-25554400 | Strong transcription | Cortex derived primary cultured neurospheres | brain |
18 | chr10:25554400-25563400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |